Annual EBITDA:
$341.70M+$33.37M(+10.82%)Summary
- As of today, COLL annual EBITDA is $341.70 million, with the most recent change of +$33.37 million (+10.82%) on December 31, 2024.
- During the last 3 years, COLL annual EBITDA has risen by +$255.15 million (+294.77%).
- COLL annual EBITDA is now at all-time high.
Performance
COLL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$120.13M+$27.84M(+30.16%)Summary
- As of today, COLL quarterly EBITDA is $120.13 million, with the most recent change of +$27.84 million (+30.16%) on September 30, 2025.
- Over the past year, COLL quarterly EBITDA has increased by +$23.65 million (+24.52%).
- COLL quarterly EBITDA is now at all-time high.
Performance
COLL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$388.72M+$23.65M(+6.48%)Summary
- As of today, COLL TTM EBITDA is $388.72 million, with the most recent change of +$23.65 million (+6.48%) on September 30, 2025.
- Over the past year, COLL TTM EBITDA has increased by +$27.25 million (+7.54%).
- COLL TTM EBITDA is now at all-time high.
Performance
COLL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
COLL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +10.8% | +24.5% | +7.5% |
| 3Y3 Years | +294.8% | +105.6% | +258.8% |
| 5Y5 Years | +5498.1% | +227.9% | +345.9% |
COLL EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +294.8% | at high | +119.0% | at high | +258.8% |
| 5Y | 5-Year | at high | +5498.1% | at high | +1379.0% | at high | +494.1% |
| All-Time | All-Time | at high | +465.7% | at high | +540.3% | at high | +485.4% |
COLL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $120.13M(+30.2%) | $388.72M(+6.5%) |
| Jun 2025 | - | $92.29M(+15.1%) | $365.06M(+2.6%) |
| Mar 2025 | - | $80.15M(-16.6%) | $355.71M(-1.3%) |
| Dec 2024 | $341.70M(+10.8%) | $96.15M(-0.3%) | $360.47M(-0.3%) |
| Sep 2024 | - | $96.47M(+16.3%) | $361.47M(+4.1%) |
| Jun 2024 | - | $82.94M(-2.3%) | $347.12M(+2.7%) |
| Mar 2024 | - | $84.91M(-12.6%) | $338.06M(+4.2%) |
| Dec 2023 | $308.33M(+77.9%) | $97.15M(+18.3%) | $324.46M(+15.0%) |
| Sep 2023 | - | $82.12M(+11.1%) | $282.15M(+9.2%) |
| Jun 2023 | - | $73.88M(+3.6%) | $258.45M(+10.4%) |
| Mar 2023 | - | $71.31M(+30.0%) | $234.11M(+35.6%) |
| Dec 2022 | $173.31M(+100.2%) | $54.85M(-6.1%) | $172.58M(+59.3%) |
| Sep 2022 | - | $58.42M(+17.9%) | $108.35M(+33.2%) |
| Jun 2022 | - | $49.54M(+406.5%) | $81.33M(+24.3%) |
| Mar 2022 | - | $9.78M(+204.1%) | $65.42M(-30.5%) |
| Dec 2021 | $86.56M(-26.7%) | -$9.39M(-129.9%) | $94.08M(-30.6%) |
| Sep 2021 | - | $31.40M(-6.7%) | $135.55M(-3.7%) |
| Jun 2021 | - | $33.64M(-12.5%) | $140.78M(+0.1%) |
| Mar 2021 | - | $38.43M(+19.8%) | $140.70M(+19.4%) |
| Dec 2020 | $118.01M(+1964.4%) | $32.08M(-12.4%) | $117.84M(+35.2%) |
| Sep 2020 | - | $36.63M(+9.2%) | $87.17M(+81.5%) |
| Jun 2020 | - | $33.56M(+115.5%) | $48.04M(+260.3%) |
| Mar 2020 | - | $15.57M(+1000.5%) | $13.33M(+259.4%) |
| Dec 2019 | -$6.33M | $1.42M(+156.4%) | -$8.36M(-149.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$2.51M(-118.2%) | $17.06M(-58.3%) |
| Jun 2019 | - | -$1.15M(+81.2%) | $40.94M(-39.2%) |
| Mar 2019 | - | -$6.12M(-122.8%) | $67.30M(-25.4%) |
| Dec 2018 | $91.91M(+223.7%) | $26.84M(+25.6%) | $90.22M(+89.0%) |
| Sep 2018 | - | $21.38M(-15.2%) | $47.73M(+265.5%) |
| Jun 2018 | - | $25.21M(+50.1%) | $13.06M(+139.2%) |
| Mar 2018 | - | $16.80M(+207.3%) | -$33.28M(+54.4%) |
| Dec 2017 | -$74.27M(+20.5%) | -$15.65M(-17.7%) | -$73.05M(+13.7%) |
| Sep 2017 | - | -$13.30M(+37.1%) | -$84.68M(+13.2%) |
| Jun 2017 | - | -$21.13M(+8.0%) | -$97.56M(+3.3%) |
| Mar 2017 | - | -$22.97M(+15.8%) | -$100.85M(-7.9%) |
| Dec 2016 | -$93.43M(-249.4%) | -$27.28M(-4.3%) | -$93.43M(-23.7%) |
| Sep 2016 | - | -$26.17M(-7.1%) | -$75.54M(-28.9%) |
| Jun 2016 | - | -$24.43M(-57.2%) | -$58.60M(-51.4%) |
| Mar 2016 | - | -$15.54M(-65.4%) | -$38.70M(-44.7%) |
| Dec 2015 | -$26.74M(-53.0%) | -$9.39M(-1.8%) | -$26.73M(-29.6%) |
| Sep 2015 | - | -$9.23M(-103.7%) | -$20.62M(-15.5%) |
| Jun 2015 | - | -$4.53M(-26.4%) | -$17.85M(-2.8%) |
| Mar 2015 | - | -$3.58M(-9.2%) | -$17.36M(+0.6%) |
| Dec 2014 | -$17.48M(-9.6%) | -$3.28M(+49.2%) | -$17.48M(-23.1%) |
| Sep 2014 | - | -$6.46M(-59.8%) | -$14.20M(-83.5%) |
| Jun 2014 | - | -$4.04M(-9.3%) | -$7.74M(-109.3%) |
| Mar 2014 | - | -$3.70M | -$3.70M |
| Dec 2013 | -$15.95M | - | - |
FAQ
- What is Collegium Pharmaceutical, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. annual EBITDA year-on-year change?
- What is Collegium Pharmaceutical, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. quarterly EBITDA year-on-year change?
- What is Collegium Pharmaceutical, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. TTM EBITDA year-on-year change?
What is Collegium Pharmaceutical, Inc. annual EBITDA?
The current annual EBITDA of COLL is $341.70M
What is the all-time high annual EBITDA for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high annual EBITDA is $341.70M
What is Collegium Pharmaceutical, Inc. annual EBITDA year-on-year change?
Over the past year, COLL annual EBITDA has changed by +$33.37M (+10.82%)
What is Collegium Pharmaceutical, Inc. quarterly EBITDA?
The current quarterly EBITDA of COLL is $120.13M
What is the all-time high quarterly EBITDA for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high quarterly EBITDA is $120.13M
What is Collegium Pharmaceutical, Inc. quarterly EBITDA year-on-year change?
Over the past year, COLL quarterly EBITDA has changed by +$23.65M (+24.52%)
What is Collegium Pharmaceutical, Inc. TTM EBITDA?
The current TTM EBITDA of COLL is $388.72M
What is the all-time high TTM EBITDA for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high TTM EBITDA is $388.72M
What is Collegium Pharmaceutical, Inc. TTM EBITDA year-on-year change?
Over the past year, COLL TTM EBITDA has changed by +$27.25M (+7.54%)